Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis

• Published in: PloS one Vol. 15; no. 6; p. e0234173
• Main Authors: Labrosse, Julie, Osdoit, Marie, Hamy, Anne-Sophie, Coussy, Florence, Pierga, Jean-Yves, Reyal, Fabien, Laas, Enora
• Format: Journal Article
• Language: English
• Published: San Francisco Public Library of Science 05.06.2020; Public Library of Science (PLoS)
• Subjects: Adjuvant chemotherapy; Biology and Life Sciences; Body mass index; Breast cancer; Cancer; Cancer patients; Cancer therapies; Cancer treatment; Care and treatment; Chemotherapy; Diseases; Endocrine therapy; Gynecology and obstetrics; Human health and pathology; Invasiveness; Ixabepilone; Laboratories; Life Sciences; Lymphatic system; Mammography; Mastectomy; Matching; Medical prognosis; Medical research; Medicine and Health Sciences; Neoadjuvant therapy; Novels; Oncology; Patient outcomes; Patients; Pharmaceutical sciences; Pharmacology; Radiation therapy; Surgery; Survival; Toxicity; Tumors; Vincristine; Vinorelbine; Women; Women's health; Zoledronate; France

Although identified to be at a higher risk of relapse, no consensus exists on the treatment of breast cancer (BC) patients with no pathological complete response after neoadjuvant chemotherapy (NAC). The benefit of adjuvant chemotherapy (ADJ) in this context has scarcely been studied. We evaluated t...